1. P112 The use of quantitative proteomics to assess the impact of reflux aspiration on cystic fibrosis lung disease. (December 2018) Authors: Lord, RW; Maher, RE; Harman, VM; Treadway, S; Bianco, B; Barry, PJ; Whorwell, PJ; Jones, R; McNamara, P; Beynon, RJ; Smith, JA; Jones, AM Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S18 The sputum proteome and its relationship to cystic fibrosis lung disease: using global proteomics to develop clinically useful biomarkers. (12th November 2019) Authors: Lord, RW; Maher, RE; Harman, V; Bianco, B; Whorwell, PJ; McNamara, PS; Smith, JA; Beynon, RJ; Jones, AM Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S26 Untargeted sputum proteomics reveals anti-inflammatory effects of CFTR modulation. (11th November 2022) Authors: Maher, RE; Barrett, E; Barry, PJ; Emmott, E; Jones, AM; McNamara, PS; Smith, JA; Tewksbury, D; Lord, RW Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗